Rebecca Meshaw

Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers

Yutian Feng, Rebecca Meshaw, Darryl McDougald et al. · Scientific Reports · 2022 · 30 citations · Full text

Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose²¹¹At-Labeled Anti-HER2 Single-Domain Antibody Fragment

Yutian Feng, Rebecca Meshaw, Xiaoguang Zhao et al. · Journal of Nuclear Medicine · 2022 · 29 citations · Full text

Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent

Yutian Feng, Zhengyuan Zhou, Darryl McDougald et al. · Nuclear Medicine and Biology · 2020 · 23 citations · Full text

Site-specific Radioiodination, Immunocytochemical Technique, Immunology +4

Site-Specific and Residualizing Linker for ¹⁸F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment

Zhengyuan Zhou, Rebecca Meshaw, Michael R. Zalutsky et al. · Journal of Nuclear Medicine · 2021 · 23 citations · Full text

Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent

Yutian Feng, Samantha M. Sarrett, Rebecca Meshaw et al. · Journal of Medicinal Chemistry · 2022 · 19 citations · Full text